November 16, 2009...1:00 pm

Drug Companies Rush To Raise Prices Before Reducing Them For Obama

Jump to Comments

Remember when the nation’s pharmaceutical companies pledged their support for the president’s health care plan by promising the shave $8 billion a year off the nation’s drug bill?  Only the most die-hard Kool-Aid addicts bought that one.  The rest of us knew that something was cooking.

Voila!

Even as drug makers promise to support Washington’s health care overhaul by shaving $8 billion a year off the nation’s drug costs after the legislation takes effect, the industry has been raising its prices at the fastest rate in years.

In the last year, the industry has raised the wholesale prices of brand-name prescription drugs by about 9 percent, according to industry analysts. That will add more than $10 billion to the nation’s drug bill, which is on track to exceed $300 billion this year. By at least one analysis, it is the highest annual rate of inflation for drug prices since 1992.

The drug trend is distinctly at odds with the direction of the Consumer Price Index, which has fallen by 1.3 percent in the last year.

Drug makers say they have valid business reasons for the price increases. Critics say the industry is trying to establish a higher price base before Congress passes legislation that tries to curb drug spending in coming years.

“When we have major legislation anticipated, we see a run-up in price increases,” says Stephen W. Schondelmeyer, a professor of pharmaceutical economics at the University of Minnesota. He has analyzed drug pricing for AARP, the advocacy group for seniors that supports the House health care legislation that the drug industry opposes.

A Harvard health economist, Joseph P. Newhouse, said he found a similar pattern of unusual price increases after Congress added drug benefits to Medicare a few years ago, giving tens of millions of older Americans federally subsidized drug insurance. Just as the program was taking effect in 2006, the drug industry raised prices by the widest margin in a half-dozen years.

“They try to maximize their profits,” Mr. Newhouse said.

Duh.

Here’s another newsflash.  It’s not evil to maximize profits.  It’s evil when private enterprise gets in bed with the government.  Everything wrong with big pharma and the insurance industries can be traced directly to their involvement with this wicked mistress.

Subscribe to Jane’s daily email.
Subscribe to Jane Q. by RSS Feed

Leave a Reply